D-pinitol inhibits Th1 polarization via the suppression of dendritic cells
- Authors
- Lee, Jun Sik; Jung, In Duk; Jeong, Young-Il; Lee, Chang-Min; Shin, Yong Kyoo; Lee, Sang-Yull; Suh, Dong-Soo; Yoon, Man-Soo; Lee, Kyu-Sub; Choi, Yung Hyun; Chung, Hae Young; Park, Yeong-Min
- Issue Date
- Jun-2007
- Publisher
- ELSEVIER SCIENCE BV
- Keywords
- D-pinitol; dendritic cell; Th1 polarization; IFN-gamma; NF-kappa B; IL-12
- Citation
- INTERNATIONAL IMMUNOPHARMACOLOGY, v.7, no.6, pp 791 - 804
- Pages
- 14
- Journal Title
- INTERNATIONAL IMMUNOPHARMACOLOGY
- Volume
- 7
- Number
- 6
- Start Page
- 791
- End Page
- 804
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/24062
- DOI
- 10.1016/j.intimp.2007.01.018
- ISSN
- 1567-5769
1878-1705
- Abstract
- D-pinitol has been demonstrated to exert insulin-like and anti-inflammatory effects. However, the effects of the maturation and immunostimulatory functions of dendritic cells (DC) remain to be clearly elucidated. In this study, we have attempted to determine whether D-pinitol regulates surface molecule expression, cytokine production, endocytosis capacity, and underlying signaling pathways in murine bone marrow-derived DC. We also attempted to ascertain whether D-pinitol could influence Th1/Th2 immune response in vivo. The DC used in this study were derived from murine bone marrow cells, and were used as immature or LPS-stimulated mature DC. The DC were then assessed with regard to surface molecule expression, dextran-FITC uptake, cytokine production, capacity to induce T-cell differentiation, and underlying signaling pathways. D-pinitol was shown to significantly inhibit CD80, CD86, MHC class I, and MHC class II expression in the LPS-stimulated mature DC. The DC also evidenced impaired IL-12 expression and IFN-gamma production. The D-pinitol-treated DC were found to be highly efficient in regards to Ag capture via mannose receptor-mediated endocytosis. D-pinitol was also demonstrated to inhibit LPS-induced MAPKs activation and NF-KB nuclear translocation. Moreover, the D-pinitol-treated DC manifested impaired induction of Th I responses, and normal cell-mediated immune responses. These novel findings provide new insight into the immunopharmacological role of D-pinitol in terms of its effects on DC. These findings also broaden current perspectives concerning our understanding of the immunopharmacological functions of D-pinitol, and have ramifications for the development of therapeutic adjuvants for the treatment of DC-related acute and chronic diseases. (C) 2007 Elsevier B.V. All rights reserved.
- Files in This Item
-
- Appears in
Collections - College of Medicine > College of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.